Showing results (111-120 of 288) with videos related to
Sort By:
Pageof 29
Journal of the American College of Cardiology|October 28, 2017
Lesion Complexity and Outcomes of Extended Dual Antiplatelet Therapy After Percutaneous Coronary InterventionRobert W Yeh, Dean J Kereiakes, P Gabriel Steg, et al.Journal of Neurochemistry|March 16, 2026
Neurotrophic Modulation Restores Motor and Developmental Defects in Zebrafish Models of ints11 DeficiencyAnna Pistocchi, Elena Chiricozzi, Matilde Molteni, et al.International Journal of Cardiology|April 29, 2023
Temporal trends in the prevalence and severity of aortic stenosis within a contemporary and diverse community-based cohortAndrew P Ambrosy, Alan S Go, Thomas K Leong, et al.Glycoconjugate Journal|March 26, 2003
Structure of the main ganglioside from the brain of Xenopus laevisAngela Maria Rizzo, Bruno Berra, Federica Rossi, et al.JACC. Cardiovascular Interventions|June 23, 2009
Impact of target lesion and nontarget lesion cardiac events on 5-year clinical outcomes after sirolimus-eluting or bare-metal stentingRiya Chacko, Meredith Mulhearn, Victor Novack, et al.JACC. Cardiovascular Interventions|October 23, 2010
Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) trialMartin B Leon, Eugenia Nikolsky, Donald E Cutlip, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 6, 2013
Long-term efficacy and safety of Zotarolimus-eluting stent in patients with diabetes mellitus: pooled 5-year results from the ENDEAVOR III and IV trialsMoshe Vardi, David A Burke, Sripal Bangalore, et al.Circulation. Cardiovascular Quality and Outcomes|November 21, 2013
Instrumental variable analysis to compare effectiveness of stents in the extremely elderlyRobert W Yeh, Samip Vasaiwala, Daniel E Forman, et al.American Heart Journal|July 7, 2020
Transcatheter InterAtrial Shunt Device for the treatment of heart failure: Rationale and design of the pivotal randomized trial to REDUCE Elevated Left Atrial Pressure in Patients with Heart Failure II (REDUCE LAP-HF II)Natalia Berry, Laura Mauri, Ted Feldman, et al.American Heart Journal|July 6, 2010
The EVEREST II Trial: design and rationale for a randomized study of the evalve mitraclip system compared with mitral valve surgery for mitral regurgitationLaura Mauri, Pallav Garg, Joseph M Massaro, et al.Pageof 29